Jay Schmelter
Founder at RiverVest Venture Management LLC
Net worth: 20 763 $ as of 30/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Horace Richard Davis | M | - |
Poseidon Medical, Inc.
 Poseidon Medical, Inc. Medical SpecialtiesHealth Technology Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC. | 21 years |
| Judy Gonzalez | F | - |
Poseidon Medical, Inc.
Poseidon Medical, Inc. Medical SpecialtiesHealth Technology Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC. | - |
| Aaron V. Kaplan | M | - |
Poseidon Medical, Inc.
Poseidon Medical, Inc. Medical SpecialtiesHealth Technology Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC. | 21 years |
| Adam Berman | M | - |
InterVene, Inc.
 InterVene, Inc. Electronic Equipment/InstrumentsElectronic Technology InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA.
Alleviant Medical, Inc.
 Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX. | 5 years |
| Jeffrey J. Peters | M | 56 |
Cardialen, Inc.
 Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | 7 years |
| Poppy Keller | F | - |
RiverVest Venture Management LLC
 RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 19 years |
| Ronald Borchardt | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 9 years |
| Ginger Glaser | F | - |
InterVene, Inc.
InterVene, Inc. Electronic Equipment/InstrumentsElectronic Technology InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA. | 3 years |
| Isaac Zike | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 5 years |
| Jacob Kriegel | M | - |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX. | 7 years |
| Pascal Krotee | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 3 years |
| Fletcher Wilson | M | - |
InterVene, Inc.
InterVene, Inc. Electronic Equipment/InstrumentsElectronic Technology InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA. | 13 years |
| Niall O'Donnell | M | 51 |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 18 years |
| Warren Watson | M | 71 |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | 12 years |
| Tom Melzer | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 24 years |
| Kelly Cathey | F | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 24 years |
| Michael Berman | M | 66 |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 20 years |
| Jeffrey M. Elkins | M | - |
InterVene, Inc.
InterVene, Inc. Electronic Equipment/InstrumentsElectronic Technology InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA. | - |
| Thomas Thaler | M | 68 |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | 6 years |
| Catherine Matthes | F | - |
InterVene, Inc.
InterVene, Inc. Electronic Equipment/InstrumentsElectronic Technology InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA. | 3 years |
| Alessandro Sette | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 2 years |
| Jared Rutter | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 6 years |
| Courtney Harris | F | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 3 years |
| John McKearn | M | 70 |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 16 years |
| Mary Byron | F | - |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX. | - |
| Chris Kastor | M | - |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX. | - |
| Ashok Gowda, | - | - |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX. | - |
| Andrew Kleiboeker | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 4 years |
| Anna Phil | M | 36 |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | - |
| Chris Kaster | M | 53 |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX. | 5 years |
| Curtis Rother | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 7 years |
| Sivan Weitzman | F | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 5 years |
| Derek Rapp | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 5 years |
| Bill Schmidt | M | - |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | 11 years |
| Ashok Gowda | M | - |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX. | - |
| John Dipersio | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 10 years |
| Alejandro J. Sanchez | M | - |
Poseidon Medical, Inc.
Poseidon Medical, Inc. Medical SpecialtiesHealth Technology Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC. | - |
| William Schmidt | M | - |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | 11 years |
| Russell J. Rottiers | M | - |
Poseidon Medical, Inc.
Poseidon Medical, Inc. Medical SpecialtiesHealth Technology Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC. | - |
| Joe Biller | M | - |
InterVene, Inc.
InterVene, Inc. Electronic Equipment/InstrumentsElectronic Technology InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA. | - |
| Michael Healy | M | - |
Poseidon Medical, Inc.
Poseidon Medical, Inc. Medical SpecialtiesHealth Technology Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC. | - |
| Paul Enever | M | 49 |
Poseidon Medical, Inc.
Poseidon Medical, Inc. Medical SpecialtiesHealth Technology Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC. | 5 years |
| Maria Berkman | M | - |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX. | 5 years |
| Douglas E. Ferguson | M | - |
Poseidon Medical, Inc.
Poseidon Medical, Inc. Medical SpecialtiesHealth Technology Tryton Medical, Inc. manufactures and sells stent systems for the treatment of bifurcation lesions. Its tri-zone technology provides scaffolding within the side branch, radial strength in the transition zone and minimal coverage in the main vessel zone. The firm also provides side branch stent systems which are used to treat a range of bifurcated lesions. The company was founded by H. Richard Davis, Aaron V. Kaplan and Dan Cole in 2003 and is headquartered in Durham, NC. | - |
| Karen Spilizewski | F | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 16 years |
| Kirk Nielsen | M | 50 |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Alleviant Medical, Inc. operates as a medical device company, which is developing potential therapies for congestive heart failure. The company was founded by Christopher Alex Arevalos, Albertien Greijdanus, Avni Patel and Jacob Kriegel in February 2017 and is headquartered in Austin, TX. | - |
| Peter Tontonoz | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark J. Mendel | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 5 years |
| Douglas F. Londal | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Duncan Dashiff | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Linnea Conrad Roberts | F | - |
The University of Chicago Booth School of Business
| 2 years |
| Gregory Anton Johnsen | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Jay J. Stock | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Noriaki Goto | M | 62 |
The University of Chicago Booth School of Business
| 2 years |
| Juan Calle Restrepo | M | 58 |
The University of Chicago Booth School of Business
| 2 years |
| Paul Thomas Quistberg | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Jason Wu | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Noreen Skelly | F | 59 |
The University of Chicago Booth School of Business
| 2 years |
| Marc Ernaelsteen | M | - |
The University of Chicago Booth School of Business
| 1 years |
| Dan Hoskins | M | - |
The University of Chicago Booth School of Business
| - |
| Brian D. Hughes | M | 56 |
The University of Chicago Booth School of Business
| 2 years |
| Guy P. Haselmann | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Nicholas Colas | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Rafael Solis | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Nadia Bervaes | F | - |
The University of Chicago Booth School of Business
| 2 years |
| Dan Horn | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Platon Chaldeos | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Andrew Jones | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Jeffrey Clark | M | - |
The University of Chicago Booth School of Business
| 3 years |
| Corinne Noyes | F | 56 |
The University of Chicago Booth School of Business
| 2 years |
| Scott M. Anderson | M | - |
The University of Chicago Booth School of Business
| 3 years |
| Steve Byrd | M | - |
The University of Chicago Booth School of Business
| 3 years |
| Bradford Phillips | M | 59 |
The University of Chicago Booth School of Business
| 2 years |
| Michael O'Hare | M | 55 |
The University of Chicago Booth School of Business
| 2 years |
| Mark Phelan | M | 55 |
The University of Chicago Booth School of Business
| 3 years |
| John Gordon Foulkes | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 5 years |
| Kevin Cureton | M | 63 |
The University of Chicago Booth School of Business
| 2 years |
| Kent Arthur Clark | M | - |
The University of Chicago Booth School of Business
| 5 years |
| Andrew B. Craig | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 19 years |
| Peer Schatz | M | 57 |
The University of Chicago Booth School of Business
| 2 years |
| Michael Alan Vitek | M | 57 |
The University of Chicago Booth School of Business
| 2 years |
| Daniel Zaldivar | M | - |
The University of Chicago Booth School of Business
| 2 years |
| John David Doughty | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Thomas Hense | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Scott Naisbitt | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 6 years |
| David A. Hoag | M | 59 |
The University of Chicago Booth School of Business
| 2 years |
| Jeff Yu | M | - |
Crescendo Venture Management LLP
 Crescendo Venture Management LLP Investment ManagersFinance Crescendo Management LLC (Crescendo Ventures) is a venture capital firm founded in 1993 by David Spreng, Mitchell Dann and Jeff Tollefson. The firm is headquartered in Palo Alto, California. | 7 years |
| Tom Seto | M | 62 |
The University of Chicago Booth School of Business
| 2 years |
| Dennis Wahr | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 5 years |
| Allan David Weine | M | 59 |
The University of Chicago Booth School of Business
| 2 years |
| Eric V. Stafford | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Jeff Hinck | M | - |
Crescendo Venture Management LLP
Crescendo Venture Management LLP Investment ManagersFinance Crescendo Management LLC (Crescendo Ventures) is a venture capital firm founded in 1993 by David Spreng, Mitchell Dann and Jeff Tollefson. The firm is headquartered in Palo Alto, California. | - |
| Louis Zahorak | M | - |
The University of Chicago Booth School of Business
| 3 years |
| David Abraham | M | - |
The University of Chicago Booth School of Business
| 2 years |
| De Miao Zhu | M | 60 |
The University of Chicago Booth School of Business
| 2 years |
| Nancy Hong | M | - |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | 7 years |
| Marc Samuel Usem | M | 60 |
The University of Chicago Booth School of Business
| 2 years |
| David Kratochvil | M | 58 |
The University of Chicago Booth School of Business
| 2 years |
| Daniel Earl Allen | M | - |
The University of Chicago Booth School of Business
| 2 years |
| Jim Riley | M | - |
The University of Chicago Booth School of Business
| - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jay Schmelter
- Personal Network
